366 related articles for article (PubMed ID: 19749791)
1. Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation.
Montano X
Oncogene; 2009 Oct; 28(43):3787-800. PubMed ID: 19749791
[TBL] [Abstract][Full Text] [Related]
2. SHP-1 negatively regulates neuronal survival by functioning as a TrkA phosphatase.
Marsh HN; Dubreuil CI; Quevedo C; Lee A; Majdan M; Walsh GS; Hausdorff S; Said FA; Zoueva O; Kozlowski M; Siminovitch K; Neel BG; Miller FD; Kaplan DR
J Cell Biol; 2003 Dec; 163(5):999-1010. PubMed ID: 14662744
[TBL] [Abstract][Full Text] [Related]
3. P53 associates with trk tyrosine kinase.
Montano X
Oncogene; 1997 Jul; 15(3):245-56. PubMed ID: 9233759
[TBL] [Abstract][Full Text] [Related]
4. Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells.
Lin J; Jin X; Rothman K; Lin HJ; Tang H; Burke W
Cancer Res; 2002 Jan; 62(2):376-80. PubMed ID: 11809683
[TBL] [Abstract][Full Text] [Related]
5. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
Zhang Y; Dang C; Ma Q; Shimahara Y
Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
[TBL] [Abstract][Full Text] [Related]
6. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor NF-Y induces apoptosis in cells expressing wild-type p53 through E2F1 upregulation and p53 activation.
Gurtner A; Fuschi P; Martelli F; Manni I; Artuso S; Simonte G; Ambrosino V; Antonini A; Folgiero V; Falcioni R; Sacchi A; Piaggio G
Cancer Res; 2010 Dec; 70(23):9711-20. PubMed ID: 20952509
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic mutant p53 increases Bcl-2 expression in estrogen receptor-positive breast cancer cells.
Pratt MA; White D; Kushwaha N; Tibbo E; Niu MY
Apoptosis; 2007 Apr; 12(4):657-69. PubMed ID: 17252199
[TBL] [Abstract][Full Text] [Related]
9. p53 is required for nerve growth factor-mediated differentiation of PC12 cells via regulation of TrkA levels.
Zhang J; Yan W; Chen X
Cell Death Differ; 2006 Dec; 13(12):2118-28. PubMed ID: 16729028
[TBL] [Abstract][Full Text] [Related]
10. c-abl is involved in the association of p53 and trk A.
Brown A; Browes C; Mitchell M; Montano X
Oncogene; 2000 Jun; 19(26):3032-40. PubMed ID: 10871855
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of the tyrosine phosphatase SHP-1 defines a subset of high-grade breast tumors.
Insabato L; Amelio I; Quarto M; Zannetti A; Tolino F; de Mauro G; Cerchia L; Riccio P; Baumhoer D; Condorelli G; Terracciano L; de Franciscis V
Oncology; 2009; 77(6):378-84. PubMed ID: 20090381
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effect of SHP-1 gene transfer on the proliferation of breast cancer cell line MDA-MB-231].
Xie YL; Liang JZ; Liu FY; Zhang JY; Xie JM; Luo RC; Li R
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1024-7. PubMed ID: 20501384
[TBL] [Abstract][Full Text] [Related]
14. Methionine inhibits cellular growth dependent on the p53 status of cells.
Benavides MA; Oelschlager DK; Zhang HG; Stockard CR; Vital-Reyes VS; Katkoori VR; Manne U; Wang W; Bland KI; Grizzle WE
Am J Surg; 2007 Feb; 193(2):274-83. PubMed ID: 17236862
[TBL] [Abstract][Full Text] [Related]
15. Interaction between p53 and TGF beta 1 in control of epithelial cell proliferation.
Blaydes JP; Schlumberger M; Wynford-Thomas D; Wyllie FS
Oncogene; 1995 Jan; 10(2):307-17. PubMed ID: 7838530
[TBL] [Abstract][Full Text] [Related]
16. Notch1 activation reduces proliferation in the multipotent hematopoietic progenitor cell line FDCP-mix through a p53-dependent pathway but Notch1 effects on myeloid and erythroid differentiation are independent of p53.
Henning K; Heering J; Schwanbeck R; Schroeder T; Helmbold H; Schäfer H; Deppert W; Kim E; Just U
Cell Death Differ; 2008 Feb; 15(2):398-407. PubMed ID: 18049480
[TBL] [Abstract][Full Text] [Related]
17. siRNA targeting NBS1 or XIAP increases radiation sensitivity of human cancer cells independent of TP53 status.
Ohnishi K; Scuric Z; Schiestl RH; Okamoto N; Takahashi A; Ohnishi T
Radiat Res; 2006 Sep; 166(3):454-62. PubMed ID: 16972754
[TBL] [Abstract][Full Text] [Related]
18. IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1.
Taylor A; Akdis M; Joss A; Akkoç T; Wenig R; Colonna M; Daigle I; Flory E; Blaser K; Akdis CA
J Allergy Clin Immunol; 2007 Jul; 120(1):76-83. PubMed ID: 17531298
[TBL] [Abstract][Full Text] [Related]
19. [Retrovirus-mediated SHP-1 gene expression in human breast cancer MDA-MB-231 cells].
Liang JZ; Li R; Zhang JY; Zheng H; Luo RC
Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):902-5. PubMed ID: 19460704
[TBL] [Abstract][Full Text] [Related]
20. Targeted repression of bone morphogenetic protein 7, a novel target of the p53 family, triggers proliferative defect in p53-deficient breast cancer cells.
Yan W; Chen X
Cancer Res; 2007 Oct; 67(19):9117-24. PubMed ID: 17909016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
